Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Haematologica|September 1, 1989
Adult acute lymphoblastic leukemia: description and analysis of long-term survivors. A retrospective studyF Giona, M G Mazzucconi, M A Aloe Spiriti, et al.British Journal of Haematology|February 19, 2002
Melphalan treatment in patients with myelofibrosis with myeloid metaplasiaM C Petti, R Latagliata, T Spadea, et al.British Journal of Haematology|May 1, 1990
Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patientsG Visani, C Finelli, U Castelli, et al.Haematologica|March 1, 1993
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes. An interim reportM A Aloe Spiriti, M C Petti, R Latagliata, et al.Leukemia & Lymphoma|April 28, 2000
Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs inductionR Latagliata, M Breccia, A Pulsoni, et al.Leukemia & Lymphoma|January 1, 1993
Is recombinant human erythropoietin treatment in myelodysplastic syndromes worthwhile?M A Aloe Spiriti, M C Petti, R Latagliata, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2009
Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending storyA Bari, L Marcheselli, S Sacchi, et al.Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.Leukemia|April 1, 1993
Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemiaA Spadea, M C Petti, P Fazi, et al.Diagnostic and Clinical Immunology|January 1, 1987
CALLA-negative, TdT- and CD7-positive acute lymphoblastic leukemia: a phenotype associated with poor prognosisG De Rossi, M A Aloe Spiriti, A Cafolla, et al.Pageof 3